Literature DB >> 3770192

Chiral purity of nucleotides as a necessary condition of complementarity.

V I Goldanskii, V A Avetisov, V V Kuz'min.   

Abstract

This work discusses the question about the role of chiral purity (homochirality) of nucleotides in the formation of complementary replicas. A qualitative answer to this question can be obtained from molecular models constructed to simulate the chiral defect in the polynucleotidic chain. It shows the necessity of homochirality of nucleotides for the complementarity preservation. The necessity of the strong mirror-symmetry breaking in the abiogenic formation of the self-replicating oligonucleotide structures is discussed in the context of prebiological evolution.

Entities:  

Mesh:

Year:  1986        PMID: 3770192     DOI: 10.1016/0014-5793(86)80036-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  A toy model for the generation of homochirality during polymerization.

Authors:  P G H Sandars
Journal:  Orig Life Evol Biosph       Date:  2003-12       Impact factor: 1.950

2.  Homochirality in life: two equal runners, one tripped.

Authors:  Mark M Green; Vipul Jain
Journal:  Orig Life Evol Biosph       Date:  2009-11-13       Impact factor: 1.950

Review 3.  Mirror symmetry breaking at the molecular level.

Authors:  V Avetisov; V Goldanskii
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Chiral Monomers Ensure Orientational Specificity of Monomer Binding During Polymer Self-Replication.

Authors:  Hemachander Subramanian; Robert A Gatenby
Journal:  J Mol Evol       Date:  2018-05-03       Impact factor: 2.395

5.  Dual role of hydrophobic racemic thioesters of alpha-amino acids in the generation of isotactic peptides and co-peptides in water; implications for the origin of homochirality.

Authors:  Roni A Illos; Gilles Clodic; Gerard Bolbach; Isabelle Weissbuch; Meir Lahav
Journal:  Orig Life Evol Biosph       Date:  2009-11-13       Impact factor: 1.950

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.